(CRNC) Cerence - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1567271093
AI Assistant, Edge, Cloud, Speech, NLP
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 99.2% |
| Value at Risk 5%th | 127% |
| Relative Tail Risk | -21.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 31.08 |
| CAGR/Max DD | -0.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.540 |
| Beta | 2.820 |
| Beta Downside | 2.032 |
| Drawdowns 3y | |
|---|---|
| Max DD | 93.25% |
| Mean DD | 55.88% |
| Median DD | 64.39% |
Description: CRNC Cerence October 25, 2025
Cerence Inc. (NASDAQ:CRNC) develops AI-driven virtual assistants tailored for the mobility and transportation sector across North America, Europe, the Middle East, Africa, Japan, and the broader Asia-Pacific region. Its product stack includes edge-deployed software, cloud-connected services, and professional integration support, delivering conversational AI capabilities such as speech recognition, natural-language understanding, speech enhancement, text-to-speech, and acoustic modeling.
Key recent metrics (as of FY 2024) indicate the company generated approximately $210 million in revenue, reflecting a year-over-year growth rate of roughly 28 %-driven largely by expanding OEM contracts and the rollout of over-the-air updates for in-vehicle assistants. The broader automotive AI market is projected to expand at a compound annual growth rate (CAGR) of 23 % through 2030, underscoring a favorable macro-trend for Cerence’s technology. A strategic partnership with Arm’s Kleidi team aims to boost the performance of its CaLLM Edge platform, potentially reducing inference latency by up to 40 % on automotive-grade silicon.
If you want a data-rich, quantitative deep-dive into Cerence’s valuation and risk profile, consider exploring the analyst tools and model inputs available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-18.7m TTM) > 0 and > 6% of Revenue (6% = 15.1m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 5.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 33.79% (prev 14.69%; Δ 19.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 61.2m > Net Income -18.7m (YES >=105%, WARN >=100%) |
| Net Debt (133.1m) to EBITDA (11.9m) ratio: 11.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (43.3m) change vs 12m ago 3.52% (target <= -2.0% for YES) |
| Gross Margin 72.07% (prev 73.52%; Δ -1.44pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 37.78% (prev 47.20%; Δ -9.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.14 (EBITDA TTM 11.9m / Interest Expense TTM 10.2m) >= 6 (WARN >= 3) |
Altman Z'' -6.08
| (A) 0.13 = (Total Current Assets 186.3m - Total Current Liabilities 101.2m) / Total Assets 630.6m |
| (B) -1.49 = Retained Earnings (Balance) -940.5m / Total Assets 630.6m |
| warn (B) unusual magnitude: -1.49 — check mapping/units |
| (C) 0.00 = EBIT TTM 1.40m / Avg Total Assets 666.5m |
| (D) -2.01 = Book Value of Equity -965.5m / Total Liabilities 479.9m |
| Total Rating: -6.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 36.19
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.46% |
| 3. FCF Margin 18.59% |
| 4. Debt/Equity 1.44 |
| 5. Debt/Ebitda 11.14 |
| 6. ROIC - WACC (= -11.11)% |
| 7. RoE -12.99% |
| 8. Rev. Trend -44.57% |
| 9. EPS Trend -24.39% |
What is the price of CRNC shares?
As of December 10, 2025, the stock is trading at USD 12.08 with a total of 1,145,479 shares traded.
Over the past week, the price has changed by +8.73%, over one month by +25.57%, over three months by +25.31% and over the past year by +34.97%.
Over the past week, the price has changed by +8.73%, over one month by +25.57%, over three months by +25.31% and over the past year by +34.97%.
Is CRNC a buy, sell or hold?
Cerence has received a consensus analysts rating of 3.14.
Therefor, it is recommend to hold CRNC.
- Strong Buy: 0
- Buy: 1
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRNC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.5 | 3.5% |
| Analysts Target Price | 12.5 | 3.5% |
| ValueRay Target Price | 11 | -8.7% |
CRNC Fundamental Data Overview November 30, 2025
Market Cap USD = 497.9m (497.9m USD * 1.0 USD.USD)
P/E Forward = 34.8432
P/S = 1.9776
P/B = 3.1137
Beta = 2.569
Revenue TTM = 251.8m USD
EBIT TTM = 1.40m USD
EBITDA TTM = 11.9m USD
Long Term Debt = 199.7m USD (from longTermDebt, last quarter)
Short Term Debt = 4.34m USD (from shortTermDebt, last quarter)
Debt = 217.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 133.1m USD (from netDebt column, last quarter)
Enterprise Value = 627.6m USD (497.9m + Debt 217.1m - CCE 87.5m)
Interest Coverage Ratio = 0.14 (Ebit TTM 1.40m / Interest Expense TTM 10.2m)
FCF Yield = 7.46% (FCF TTM 46.8m / Enterprise Value 627.6m)
FCF Margin = 18.59% (FCF TTM 46.8m / Revenue TTM 251.8m)
Net Margin = -7.43% (Net Income TTM -18.7m / Revenue TTM 251.8m)
Gross Margin = 72.07% ((Revenue TTM 251.8m - Cost of Revenue TTM 70.3m) / Revenue TTM)
Gross Margin QoQ = 72.55% (prev 72.80%)
Tobins Q-Ratio = 1.00 (Enterprise Value 627.6m / Total Assets 630.6m)
Interest Expense / Debt = 0.79% (Interest Expense 1.71m / Debt 217.1m)
Taxrate = -144.3% (out of range, set to none) (7.89m / -5.47m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.84 (Total Current Assets 186.3m / Total Current Liabilities 101.2m)
Debt / Equity = 1.44 (Debt 217.1m / totalStockholderEquity, last quarter 150.7m)
Debt / EBITDA = 11.14 (Net Debt 133.1m / EBITDA 11.9m)
Debt / FCF = 2.84 (Net Debt 133.1m / FCF TTM 46.8m)
Total Stockholder Equity = 144.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.97% (Net Income -18.7m / Total Assets 630.6m)
RoE = -12.99% (Net Income TTM -18.7m / Total Stockholder Equity 144.1m)
RoCE = 0.41% (EBIT 1.40m / Capital Employed (Equity 144.1m + L.T.Debt 199.7m))
RoIC = 0.32% (EBIT 1.40m / (Assets 630.6m - Curr.Liab 101.2m - Cash 87.5m))
WACC = 11.43% (E(497.9m)/V(715.0m) * Re(16.41%) + (debt cost/tax rate unavailable))
Discount Rate = 16.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.77%
[DCF Debug] Terminal Value 42.47% ; FCFE base≈32.8m ; Y1≈21.5m ; Y5≈9.85m
Fair Price DCF = 1.85 (DCF Value 83.3m / Shares Outstanding 44.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -24.39 | EPS CAGR: -57.89% | SUE: 0.80 | # QB: 0
Revenue Correlation: -44.57 | Revenue CAGR: -11.14% | SUE: 2.35 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.16 | Chg30d=+0.013 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-09-30): EPS=0.77 | Chg30d=+0.127 | Revisions Net=+1 | Growth EPS=+46.6% | Growth Revenue=+20.7%
EPS next Year (2027-09-30): EPS=0.79 | Chg30d=+0.187 | Revisions Net=-1 | Growth EPS=+1.8% | Growth Revenue=-3.0%
P/E Forward = 34.8432
P/S = 1.9776
P/B = 3.1137
Beta = 2.569
Revenue TTM = 251.8m USD
EBIT TTM = 1.40m USD
EBITDA TTM = 11.9m USD
Long Term Debt = 199.7m USD (from longTermDebt, last quarter)
Short Term Debt = 4.34m USD (from shortTermDebt, last quarter)
Debt = 217.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 133.1m USD (from netDebt column, last quarter)
Enterprise Value = 627.6m USD (497.9m + Debt 217.1m - CCE 87.5m)
Interest Coverage Ratio = 0.14 (Ebit TTM 1.40m / Interest Expense TTM 10.2m)
FCF Yield = 7.46% (FCF TTM 46.8m / Enterprise Value 627.6m)
FCF Margin = 18.59% (FCF TTM 46.8m / Revenue TTM 251.8m)
Net Margin = -7.43% (Net Income TTM -18.7m / Revenue TTM 251.8m)
Gross Margin = 72.07% ((Revenue TTM 251.8m - Cost of Revenue TTM 70.3m) / Revenue TTM)
Gross Margin QoQ = 72.55% (prev 72.80%)
Tobins Q-Ratio = 1.00 (Enterprise Value 627.6m / Total Assets 630.6m)
Interest Expense / Debt = 0.79% (Interest Expense 1.71m / Debt 217.1m)
Taxrate = -144.3% (out of range, set to none) (7.89m / -5.47m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.84 (Total Current Assets 186.3m / Total Current Liabilities 101.2m)
Debt / Equity = 1.44 (Debt 217.1m / totalStockholderEquity, last quarter 150.7m)
Debt / EBITDA = 11.14 (Net Debt 133.1m / EBITDA 11.9m)
Debt / FCF = 2.84 (Net Debt 133.1m / FCF TTM 46.8m)
Total Stockholder Equity = 144.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.97% (Net Income -18.7m / Total Assets 630.6m)
RoE = -12.99% (Net Income TTM -18.7m / Total Stockholder Equity 144.1m)
RoCE = 0.41% (EBIT 1.40m / Capital Employed (Equity 144.1m + L.T.Debt 199.7m))
RoIC = 0.32% (EBIT 1.40m / (Assets 630.6m - Curr.Liab 101.2m - Cash 87.5m))
WACC = 11.43% (E(497.9m)/V(715.0m) * Re(16.41%) + (debt cost/tax rate unavailable))
Discount Rate = 16.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.77%
[DCF Debug] Terminal Value 42.47% ; FCFE base≈32.8m ; Y1≈21.5m ; Y5≈9.85m
Fair Price DCF = 1.85 (DCF Value 83.3m / Shares Outstanding 44.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -24.39 | EPS CAGR: -57.89% | SUE: 0.80 | # QB: 0
Revenue Correlation: -44.57 | Revenue CAGR: -11.14% | SUE: 2.35 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.16 | Chg30d=+0.013 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-09-30): EPS=0.77 | Chg30d=+0.127 | Revisions Net=+1 | Growth EPS=+46.6% | Growth Revenue=+20.7%
EPS next Year (2027-09-30): EPS=0.79 | Chg30d=+0.187 | Revisions Net=-1 | Growth EPS=+1.8% | Growth Revenue=-3.0%
Additional Sources for CRNC Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle